Yi Xiao
Corporate Officer/Principal bei ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Vermögen: 4 Mio $ am 30.04.2024
Aktive Positionen von Yi Xiao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. | Corporate Officer/Principal | 01.04.2019 | - |
Asymchem Life Science Tianjin Co. Ltd.
 Asymchem Life Science Tianjin Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Asymchem Laboratories (Tianjin) Co., Ltd., Asymchem Life Science Tianjin Co. Ltd. is a pharmaceutical company that manufactures pharmaceutical raw materials. The company is based in Tianjin, China. Yi Xiao has been the CEO of the Chinese company since 2018. | Vorstandsvorsitzender | 01.05.2019 | - |
| Vorsitzender | 01.05.2019 | - | |
| Corporate Officer/Principal | 01.09.2018 | 01.05.2019 |
Karriereverlauf von Yi Xiao
Ehemalige bekannte Positionen von Yi Xiao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Bristol-Myers Squibb (China) Investment Co. Ltd. | Corporate Officer/Principal | 01.05.2006 | 01.08.2018 |
Ausbildung von Yi Xiao
| Sun Yat-Sen University | Undergraduate Degree |
| Nagoya University | Doctorate Degree |
Statistik
International
| China | 5 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| Chairman | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Asymchem Life Science Tianjin Co. Ltd.
Asymchem Life Science Tianjin Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Asymchem Laboratories (Tianjin) Co., Ltd., Asymchem Life Science Tianjin Co. Ltd. is a pharmaceutical company that manufactures pharmaceutical raw materials. The company is based in Tianjin, China. Yi Xiao has been the CEO of the Chinese company since 2018. | Health Technology |
| Bristol-Myers Squibb (China) Investment Co. Ltd. |
